Three Indian companies get licence to manufacture NASA's coronavirus ventilators
The three Indian companies are Alpha Design Technologies Pvt Ltd, Bharat Forge Ltd and Medha Servo Drives Pvt Ltd, the space organisation said in a statement on Friday. (Source: The Economic Times)
Source: The Economic Times - May 30, 2020 Category: Consumer Health News Source Type: news

57% worried of high-priced COVID-19 treatment in private hospitals: Survey
The survey conducted by LocalCircles, a community social media platform, received around 40,000 responses on five questions related to public perception of government and private hospitals for COVID-19 treatment. (Source: The Economic Times)
Source: The Economic Times - May 30, 2020 Category: Consumer Health News Source Type: news

National case fatality rate dips to 2.84%, falls below 3% for first time since April 7
The Covid-19 case fatality rate (CFR) for India was 2.84% on Friday, for the first time below 3% in the last one-and-a-half months. The rate indicates the percentage of people who have died of the pandemic among the total number of people who have tested positive. (Source: The Economic Times)
Source: The Economic Times - May 30, 2020 Category: Consumer Health News Source Type: news

Singapore SC dismisses Singh Bros' appeal against HC order
In another setback for former Ranbaxy promoters Malvinder and Shivinder Singh, a Singapore Supreme Court on Thursday dismissed their appeal against the order of the Singapore High Court which had earlier refused to set aside the arbitration award in favour of Japanese drug firm Daiichi Sankyo Inc. (Source: The Economic Times)
Source: The Economic Times - May 29, 2020 Category: Consumer Health News Source Type: news

Early action helped the state control the spread of virus: V Ravi, Karnataka Health Task Force
Karnataka and its capital Bengaluru have managed to keep coronavirus infection numbers low as compared with other regions. (Source: The Economic Times)
Source: The Economic Times - May 29, 2020 Category: Consumer Health News Source Type: news

View: Beyond the lockdown, to reduce deaths prevent the clusters
In India with the country in lockdown, we only are made aware of few clusters, namely, in Nizamuddin, Chennai vegetable market, Nanded pilgrimage and Mumbai slums. Moving forward, the formation of clusters will define the course of the epidemic in India. (Source: The Economic Times)
Source: The Economic Times - May 29, 2020 Category: Consumer Health News Source Type: news

Covid-19: New algae-based respirator may help people wearing masks breath easy
The algae in the respirator conduct photosynthesis and remove carbon dioxide (C02) and other air pollutants while producing oxygen, making the air passing through it more breathable, the researchers from Lovely Professional University (LPU) in Punjab said. (Source: The Economic Times)
Source: The Economic Times - May 29, 2020 Category: Consumer Health News Source Type: news

Symptomless COVID-19 infection may be more prevalent than thought: Study
According to the findings, published in the journal Thorax, more than four out of five of passengers and crew who tested positive for the infection had no symptoms. The researchers also noted that there is a pressing need for accurate global data on how many people have been infected so far. (Source: The Economic Times)
Source: The Economic Times - May 28, 2020 Category: Consumer Health News Source Type: news

Healthium MedTech launches anti-microbial gloves TruShield
Manufactured at Kunigal, Karnataka, these AMGs are made from a patented technology using a quaternary ammonium compound that the company said in a statement kills microbes and provides 99.99 per cent protection for healthcare professionals and patients up to eight hours. (Source: The Economic Times)
Source: The Economic Times - May 28, 2020 Category: Consumer Health News Source Type: news

Resumption of elective surgeries required to soften COVID-19 blow to healthcare sector: MTaI
Elective surgeries account for about 50 per cent of revenues for hospitals in normal business conditions. Reduced revenues have curtailed hospitals' ability to pay for supplies of pharmaceuticals, diagnostics and medical devices, thereby severely disrupting entire healthcare value chain, it added. (Source: The Economic Times)
Source: The Economic Times - May 28, 2020 Category: Consumer Health News Source Type: news

Health Ministry seeks inclusion of vulnerable groups in social protection schemes
The Health Ministry received representations from civil society organisations and key population representatives, like injecting drug users, the transgender community, female sex workers and HIV/AIDS-affected people, that they are "greatly affected" in terms of livelihood, nutrition and access to shelter and other essential services, officials said Thursday. (Source: The Economic Times)
Source: The Economic Times - May 28, 2020 Category: Consumer Health News Source Type: news

India acted as pharmacy of the world in response to coronavirus: Ministry of External Affairs
"India has acted as the pharmacy of the world and healthcare supplier to all parts of the globe. India has the ability to be a bridge between the developed and developing world and facilitating a two-way flow of information, products and expertise. There is growing interest in yoga and ayurveda," Sanjay Bhattacharyya, secretary in the MEA, said. (Source: The Economic Times)
Source: The Economic Times - May 28, 2020 Category: Consumer Health News Source Type: news

Remote control by govt leaves many pvt hospitals with that sinking feeling
Diktats by various state governments, especifically the ones in Delhi and Mumbai, have been pushing hospitals to reserve beds for Covid-19 while also introducing price caps on treatment. (Source: The Economic Times)
Source: The Economic Times - May 28, 2020 Category: Consumer Health News Source Type: news

New antibody kits may have a China link, too
After initial hiccups over validating the efficacy of Covid-19 antibody testing kits made in China, the Indian Council of Medical Research (ICMR) has started the process of approving kits made by about 15 companies from Germany, the US, Israel and China. (Source: The Economic Times)
Source: The Economic Times - May 28, 2020 Category: Consumer Health News Source Type: news

Remdesivir improves time to recovery in COVID-19 patients: Study
New York, May 27 () Remdesivir, the antiviral under clinical trials for treatment against novel coronavirus infection, is superior to the standard of care given to COVID-19 patients, according to a new study. (Source: The Economic Times)
Source: The Economic Times - May 27, 2020 Category: Consumer Health News Source Type: news

Patanjali's plea for Ayurvedic medicine trials raises eyebrows
Media reports said the district Collector approved the proposal for clinical trial of some Ayurvedic medicines of the Patanjali group on COVID-19 patients but later quashed it. Patanjali Ayurved's MD Acharya Balkrishna told that there is a need to understand the company does not want to undertake any new experiment or trial of Ayurvedic treatment regime on COVID-19 patients in Indore. (Source: The Economic Times)
Source: The Economic Times - May 27, 2020 Category: Consumer Health News Source Type: news

Indian IT helps global healthcare firms fight Covid-19
Pune-based Persistent Systems has, along with the Biocomplexity Institute, created Covid-19 response solutions for nurses as well as mobile apps for patients. (Source: The Economic Times)
Source: The Economic Times - May 27, 2020 Category: Consumer Health News Source Type: news

Talk to labs to cut test costs: Centre to states
Private laboratories have maintained that they are doing a “service to the nation” and that even with Rs 4,500 they are not able to recover their expenses and are continuing the tests at a time when non-Covid test volumes are significantly down. (Source: The Economic Times)
Source: The Economic Times - May 27, 2020 Category: Consumer Health News Source Type: news

Mixed opinion by Indian experts on WHO's temporary pause on hydroxychloroquine trial
While some experts feel that after the WHO decisions, country's medical centres will have to take HCQ and chloroquine our of the treatment regimen of COVID-19 patients, others opined it is "not binding" for India to oblige with the decision of the world body. (Source: The Economic Times)
Source: The Economic Times - May 26, 2020 Category: Consumer Health News Source Type: news

Pvt hospitals upset over Delhi's order to reserve 20% beds for Covid patients
Delhi government's directive to private hospitals to reserve 20% of the beds for Covid-19 patients has raised concerns over cohorting of patients and increasing the pandemic spread in the city. (Source: The Economic Times)
Source: The Economic Times - May 26, 2020 Category: Consumer Health News Source Type: news

Centre aims at doubling testing to 2,00,000 a day, with focus on states witnessing migrant influx
The Centre plans to double its Covid-19 testing capacity to 200,000 a day, with a special focus on states facing an influx of migrant workers. (Source: The Economic Times)
Source: The Economic Times - May 26, 2020 Category: Consumer Health News Source Type: news

Health products get a boost as desis look to build immunity
Products such as olive oil, soya oil, mustard oil, fortified bread& biscuits, and powdered chocolate drinks are in huge demand. During normal times, such products would grow at just 5-10% annually, but now they are registering annualised growth of 20-40%, industry executives say. (Source: The Economic Times)
Source: The Economic Times - May 26, 2020 Category: Consumer Health News Source Type: news

Covid-19: Tata Trusts, Tata group ties up with two medical institutions to assist health care professionals
The Trusts ’ intervention follows the Chairman, Mr. Ratan N. Tata’s statement that “urgent emergency resources need to be deployed to cope with the needs of fighting the Covid-19 crisis, which is one of the toughest challenges the human race will face.” (Source: The Economic Times)
Source: The Economic Times - May 26, 2020 Category: Consumer Health News Source Type: news

Manufacturing of PPEs, N95 masks ramped up; ensuring quality through stringent protocols: Health minister
"There are some reports in a section of the media expressing concern about the quality of personal protective equipment (PPE) coveralls," the ministry said, clarifying that the products referred to in the reports have no relevance to the procurement being made by the central government. (Source: The Economic Times)
Source: The Economic Times - May 25, 2020 Category: Consumer Health News Source Type: news

Took lessons from swine flu outbreak, devised 'intelligent testing strategy' against COVID-19: ICMR
The apex health research body said to cater to the increasing need for testing, India developed an "intelligent testing strategy to remain ahead of the virus" by significantly shoring up its diagnosis infrastructure. (Source: The Economic Times)
Source: The Economic Times - May 25, 2020 Category: Consumer Health News Source Type: news

Prices of N-95 masks down by up to 47% after NPPA advisory
N-95 masks were earlier being sold in the market for Rs 150 to 300 per unit and after the advisory by the the National Pharmaceutical Pricing Authority (NPPA), prices have been cut. (Source: The Economic Times)
Source: The Economic Times - May 25, 2020 Category: Consumer Health News Source Type: news

AICTE, CSIR to host hackathon for Covid-19 drug discovery
The hackathon is being organised by the Council of Scientific and Industrial Research (CSIR) and AICTE. The ideas submitted will be worked upon by CSIR labs, startups and other private organisations. (Source: The Economic Times)
Source: The Economic Times - May 25, 2020 Category: Consumer Health News Source Type: news

The signal in the noise: Using the best data to combat Covid-19 in India
If we ignore biases in data sets and analysis, it will hamper the efforts to defeat the virus. (Source: The Economic Times)
Source: The Economic Times - May 24, 2020 Category: Consumer Health News Source Type: news

Health infrastructure must be ramped up to ensure preparedness for next 2 months, says government
The government has asked the eleven municipal areas to step up monitoring in old cities, urban slums and other high density pockets like camps and clusters for migrant workers for management of COVID-19 cases. (Source: The Economic Times)
Source: The Economic Times - May 24, 2020 Category: Consumer Health News Source Type: news

India will have to play key role in mass production of coronavirus vaccine: France
Dozens of researchers across the globe are racing against time to come out with a vaccine for coronavirus that has infected nearly five million people and killed over 3,30,000 globally. (Source: The Economic Times)
Source: The Economic Times - May 24, 2020 Category: Consumer Health News Source Type: news

‘Replaceable filters’ for N95 masks soon
Since the outbreak of Covid-19, there's been a worldwide shortage of face masks — particularly the N95 ones worn by health care workers, they said. Although these coverings provide the highest level of protection currently available, they have limitations, the researchers noted in the journal ACS Nano. (Source: The Economic Times)
Source: The Economic Times - May 23, 2020 Category: Consumer Health News Source Type: news

Health Ministry asks states to buy PPEs from the GeM portal also
The Union Health Ministry has asked states to also directly buy Personal Protective Equipment (PPEs) from the suppliers onboarded on the Government e-Marketplace (GeM) portal in addition to the supplies of PPEs being sent by the Centre. (Source: The Economic Times)
Source: The Economic Times - May 23, 2020 Category: Consumer Health News Source Type: news

Healthcare workers hold black ribbon protest against new quarantine guidelines
As per the Union health ministry guidelines issued on May 15, healthcare workers serving in COVID-19 areas do not need to undergo quarantine unless there has been violation in the use of PPE or any other form of high-risk exposure or they have symptoms suggestive of coronavirus infection. (Source: The Economic Times)
Source: The Economic Times - May 22, 2020 Category: Consumer Health News Source Type: news

Lancet study finds no benefit for hydroxychloroquine in COVID-19 patients
The scientists said these drugs should not be used to treat COVID-19 patients outside of clinical trials until results from randomised clinical trials are available to confirm their safety and efficacy for COVID-19 patients. They explained chloroquine, an antimalarial drug and its analogue, hydroxychloroquine, are commonly used to treat autoimmune diseases. (Source: The Economic Times)
Source: The Economic Times - May 22, 2020 Category: Consumer Health News Source Type: news

Pandemic halts vaccination for nearly 80 million children
UNICEF reported a significant delay in planned vaccine deliveries due to lockdown measures and a dramatic reduction in the number of available flights. More than 40 of Africa's 54 nations have closed their borders, though some allow cargo and emergency transport. (Source: The Economic Times)
Source: The Economic Times - May 22, 2020 Category: Consumer Health News Source Type: news

Use of plasma therapy successful, claims Pune hospital
Convalescent Plasma Therapy is an experimental procedure where plasma from the blood of a recovered COVID-19 patient is transfused to a critically ill coronavirus patient. The blood of a person who has recovered from COVID-19 develops antibodies. When injected into the blood of another patient, these antibodies are supposed to help that person fight the infection. (Source: The Economic Times)
Source: The Economic Times - May 21, 2020 Category: Consumer Health News Source Type: news

1000-fold increase in quantum of COVID-19 tests: ICMR
A total of 25,12,388 samples had been tested by 9 am of May 20, and the testing capacity has been scaled up to 1 lakh tests per day, it said. (Source: The Economic Times)
Source: The Economic Times - May 21, 2020 Category: Consumer Health News Source Type: news

Govt stimulus package does not address immediate concerns of healthcare system: Fitch Solutions
On March 11, the Ministry of Finance increased allocation - 0.008 per cent of the country's GDP - to the health services division to support an expansion of healthcare spending, Fitch Solutions Country Risk and Industry Research (a unit of Fitch Group) said. (Source: The Economic Times)
Source: The Economic Times - May 21, 2020 Category: Consumer Health News Source Type: news

Dilemma for doctors as Roche ’s experimental drug for Covid-19 is ‘life-saver’ but too costly
In India, the drug sold under the brand name Actemra, is approved for the use in autoimmune disease such as rheumatoid arthritis and for six months treatment it costs Rs 2.5 lakh. For Covid-19 patients who are administered this drug, the cost is Rs 60,000 per dosage. (Source: The Economic Times)
Source: The Economic Times - May 20, 2020 Category: Consumer Health News Source Type: news

Wipro founder Azim Premji is an early investor in US firm Moderna
Wipro founder Azim Premji is an investor in Moderna, the firm that has emerged a frontrunner for Covid vaccine. (Source: The Economic Times)
Source: The Economic Times - May 20, 2020 Category: Consumer Health News Source Type: news

RIL's Nowfloats forays into tele-medicine, looks to on-board 1 lakh doctors
"We have on boarded 6,000 doctors who can provide consultation to patients over online video. Patients will not need to download a separate app for accessing doctors. They will get a link from the doctor on Whatsapp or any other messaging platform that can be accessed in a browser," Nowfloats head of research, Nikhil Salkar told. (Source: The Economic Times)
Source: The Economic Times - May 20, 2020 Category: Consumer Health News Source Type: news

Dilemma for doctors as Roche ’s Covid drug is ‘life-saver’ but too costly
In India, the drug sold under the brand name Actemra, is approved for the use in autoimmune disease such as rheumatoid arthritis and for six months treatment it costs Rs 2.5 lakh. For Covid-19 patients who are administered this drug, the cost is Rs 60,000 per dosage. (Source: The Economic Times)
Source: The Economic Times - May 20, 2020 Category: Consumer Health News Source Type: news

AIIMS to soon conduct 1st autopsy to study virus
India has decided that invasive technique should not be adopted for forensic autopsy in Covid-19 deaths as mortuary staff are exposed to potentially dangerous health risks due to organ fluids and secretions even after taking the highest precautions, say the new Standard Guidelines for Medicolegal autopsy in Covid deaths in India by the ICMR. (Source: The Economic Times)
Source: The Economic Times - May 20, 2020 Category: Consumer Health News Source Type: news

What can a COVID-19 antibody test tell us?
Studies are still underway to determine what antibody level would be needed for immunity. It's also not yet known how long any immunity might last. For now, the tests are most helpful for researchers trying to track how the virus spreads in communities. (Source: The Economic Times)
Source: The Economic Times - May 20, 2020 Category: Consumer Health News Source Type: news

Machines used for testing drug-resistant TB can be now used for confirmation of COVID-19 cases
Now, the ICMR has issued revised guidelines for TrueNat testing for COVID-1, saying the "TrueNat system is now a comprehensive assay for screening and confirmation of COVID-19 cases". According to the guidelines, all samples of suspect COVID-19 should be first tested by the E gene screening assay. (Source: The Economic Times)
Source: The Economic Times - May 20, 2020 Category: Consumer Health News Source Type: news

Over 1 crore people have availed free treatment under Ayushman Bharat so far: NHA
Also, 2,132 patients have availed or are currently undergoing treatment for COVID-19 under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojna (AB-PMJAY) in the country, the National Health Authority (NHA), which is responsible for implementing the scheme, said on Wednesday. (Source: The Economic Times)
Source: The Economic Times - May 20, 2020 Category: Consumer Health News Source Type: news

Covid-19: Amid migrant exodus, ICMR revises testing strategy
Besides an urgent drive to check migrant workers for flu and fevers, all symptomatic frontline workers involved in containment and mitigation of Covid-19 will also be tested through the gold standard RT-PCR test given the large number of such persons including Asha workers and municipal officials involved in the exercise. (Source: The Economic Times)
Source: The Economic Times - May 19, 2020 Category: Consumer Health News Source Type: news

Heavy smoking blamed for Indonesia ’s 6.6% coronavirus death rate
While smoking has been declining globally, in Indonesia it ’s still common -- and growing -- and public health experts argue it’s no coincidence that many of the 18,000-plus coronavirus patients in the vast island nation have died. The fatality rate in the country is about 6.6%. (Source: The Economic Times)
Source: The Economic Times - May 19, 2020 Category: Consumer Health News Source Type: news

E-pharmacies operating illegally via site linked to Aarogya Setu
A lobby of over 850,000 chemist outlets across India has asked the government to delink the Aarogya Setu Mitr portal from the government's Covid tracker Aarogya Setu app, saying several 'foreign-funded and illegally operating' e-pharmacies were using the portal to advance their business interests in India. (Source: The Economic Times)
Source: The Economic Times - May 19, 2020 Category: Consumer Health News Source Type: news

Mumbai hospitals unhappy with state treatment
Threats of arrests, government takeover and FIRs for letting staff get infected - that's the reality for private hospitals in Mumbai, the country's Covid-19 nerve center. (Source: The Economic Times)
Source: The Economic Times - May 19, 2020 Category: Consumer Health News Source Type: news